US Patent 7872014 Anaplastic lymphoma kinase modulators and methods of use

Patent 7872014 was granted and assigned to Exelixis on January, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Exelixis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7872014

Patent Inventor Names

Tsze H. Tsang0

Owen Joseph Bowles0

Richard G. Khoury0

Simona Costanzo0

Abigail R. Kennedy0

Angie I. Kim0

Charles M. Blazey0

Csaba J. Peto0

...

Date of Patent

January 18, 2011

Patent Application Number

10565657

Date Filed

July 23, 2004

Patent Primary Examiner

‌

Zinna N. Davis

Patent abstract

The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.